CEL-SCI CORPORATION Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
CEL-SCI CORPORATION (CVM) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -10.27% for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2025-12-29
- CEL-SCI CORPORATION effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was -10.27%.
- CEL-SCI CORPORATION effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -2.32%.
- CEL-SCI CORPORATION effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -1.62%.
- CEL-SCI CORPORATION effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -0.28%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month |
|---|---|
| 2025-09-30 | -10.27% 10-K · filed 2025-12-29 |
| 2024-09-30 | -2.32% 10-K · filed 2025-12-29 |
| 2023-09-30 | -1.62% 10-K · filed 2025-01-13 |
| 2022-09-30 | -0.28% 10-K · filed 2023-12-21 |
| 2021-09-30 | -0.79% 10-K · filed 2022-12-27 |
| 2020-09-30 | -3.24% 10-K · filed 2021-12-21 |
| 2019-09-30 | -4.77% 10-K · filed 2020-12-29 |
| 2018-09-30 | -5.95% 10-K/A · filed 2019-12-23 |
| 2017-09-30 | -3.39% 10-K · filed 2018-12-19 |
| 2016-09-30 | -0.03% 10-K · filed 2017-12-29 |
| 2015-09-30 | -0.21% 10-K/A · filed 2017-12-11 |
| 2014-09-30 | 0.00% 10-K/A · filed 2017-12-11 |
| 2013-09-30 | 0.00% 10-K · filed 2015-12-11 |
| 2012-09-30 | -0.53% 10-K · filed 2014-12-23 |
| 2011-09-30 | -0.04% 10-K · filed 2013-12-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |